Examining changes over time in CLL cell surface markers to identify cells at different stages
Current and potential PI3K and BTK inhibitors for CLL
How does a patient’s personal situation affect CLL treatment choice?
CLL2-GIVe trial: investigating chemotherapy-free treatment of CLL
The changing role of nurses in bone marrow biopsies